Read
4 minute read
November 20, 2026
4 minute read
What You Need to Know
- Regulatory analysis should begin before deal terms are finalized. Identifying securities, antitrust, trade and employment risks early gives deal teams greater flexibility over pricing, structure and timing.
- Federal merger clearance does not eliminate antitrust exposure. Deal parties must account for state enforcement, consider potential additional reporting requirements, and understand that deals can be challenged even after required competition-related waiting periods are observed.
- Regulatory uncertainty must translate into actionable deal terms. Realistic closing timelines, contractual protections and information-sharing restrictions can help organizations manage risk throughout the transaction.
Corporate legal departments must identify regulatory exposure before transaction terms are finalized, translate legal uncertainty into business decisions and allocate remaining risks through contractual protections to preserve deal certainty, legal practitioners said.
During a November 17 In-House Connect webinar sponsored by Michael Best, Amanda Wait, Partner and Antitrust & Competition Subgroup Leader at Michael Best, and Aris Haigian, Partner at Michael Best, discussed how securities, antitrust, trade and employment developments are influencing corporate dealmaking.
Wait emphasized that regulatory developments matter most to business leaders when they affect price, structure, timing or certainty. Rather than presenting executives with a list of regulatory changes, in-house counsel should explain how those developments affect the proposed transaction.
She outlined a three-step framework: see the risk, translate it into actionable business considerations and allocate remaining exposure through appropriate contractual provisions.
For example, telling a CFO that a transaction presents Hart-Scott-Rodino (HSR) Act risks provides limited practical guidance. Explaining that regulatory review could take two to four months, or potentially more than a year if a Second Request is issued, gives leadership a more useful basis for decision-making.
Timing is particularly important because the available options narrow as a transaction progresses. For example, during strategic planning, companies can reconsider potential targets, modify transaction structures or change the scope of a deal. After signing, however, their options depend largely on the contractual protections they have already negotiated.
Haigian reinforced the importance of involving experienced attorneys in due diligence. Although document review is frequently delegated to junior lawyers, identifying material issues and developing strategies to address them requires experienced legal judgment.
Securities developments present additional considerations. Haigian discussed proposed changes to federal shareholder proposal procedures, proxy requirements and reporting obligations that could affect corporate governance and transaction execution.
He cautioned that even where regulatory changes make corporate approvals easier, adequate disclosure remains essential. In transactions involving conflicts of interest, shareholder approval may not provide the intended protection if material information was omitted from the proxy statement.
“The key takeaway here is disclosure, disclosure, disclosure,” Haigian said.
Antitrust review can present an even more immediate threat to transaction timing. Wait explained that legal departments should assess realistic investigation timelines before negotiating outside closing dates.
A transaction agreement with a six-month outside date, for example, may be incompatible with an anticipated Second Request investigation lasting nine to 12 months. Without early coordination between antitrust and transactional counsel, parties could negotiate an agreement that cannot accommodate its own regulatory timeline.
Federal merger clearance also does not necessarily eliminate antitrust risk exposure. Wait encouraged counsel to assess potential state reporting requirements, industry-specific notification obligations and potential interest or challenges from federal enforcers, state attorneys general and/or private plaintiffs. Even transactions that do not trigger federal reporting requirements may face subsequent antitrust scrutiny.
Legal departments should also establish a consistent, factually supported explanation of a transaction's competitive benefits. Statements made to regulators should align with representations in board presentations, press releases and customer communications.
Wait identified three common mistakes: inadequate information-sharing restrictions, problematic language in transaction documents and premature operational coordination before closing.
“You can plan, but you can't control the business before you actually own it,” Wait said.
Trade policy further demonstrates why regulatory analysis cannot occur independently of financial and transactional planning. For example, tariff exposure within a target's supply chain could affect valuation, purchase price negotiations or assessments of material adverse changes. Identifying that exposure early allows deal teams to consider its implications before committing to economic terms.
Labor market competition introduces another potential blind spot. Wait explained that companies operating in entirely different industries may still compete for the same employees. A technology company and a bank, for example, could both recruit software engineers, creating potential labor market concerns if they combine.
Non-compete agreements can also attract scrutiny independently of whether regulators challenge the transaction itself. Counsel should therefore examine existing employment restrictions and applicable state requirements during transaction planning.
Sharing employee compensation, bonus and other sensitive workforce information during diligence creates additional risks. Wait recommended using clean teams and limiting information access where transaction participants compete for workers, rather than assuming a nondisclosure agreement alone provides sufficient protection.
“Due diligence is almost too late.” - Amanda Wait, Partner and Antitrust & Competition Subgroup Leader at Michael Best
To bring these considerations together, Wait recommended developing a regulatory heat map early in the transaction process. The exercise should identify the issues most likely to threaten closing, determine which specialists need to participate and establish how those risks will be addressed collectively.
During the audience Q&A, Wait also cautioned against assuming that reduced enforcement agency staffing would allow potentially problematic transactions to escape scrutiny. Customer complaints and public announcements can still draw regulatory attention.
“You just can't assume that you're going to fly under the radar. That is not a good business strategy,” Wait said.
Want to watch the recording? It's available via In-House Connect On-Demand.


